May 21 - May 23
Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics
Multiple clinical failures in the neurodegenerative field have sparked realization that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modeling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.
With 70+ thought-leaders converging at NDD Europe, this will be an unrivaled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network.